{
    "code": "02021701",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021701",
    "time": "2016-01-22 04:32:43",
    "許可證字號": "衛署藥輸字第021701號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/12\/29",
    "發證日期": "86\/05\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202170101",
    "中文品名": "卡伯拉丁注射液",
    "英文品名": "CARBOPLATIN INJECTION \"DBL\"",
    "適應症": "卵巢癌。",
    "劑型": "270注射劑",
    "包裝": "15.45公撮小瓶 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "CARBOPLATIN",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "新北市淡水區中正東路2段177號",
    "主製造廠": {
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平村1鄰舊厝子1之2號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004001500",
            "成分名稱": "CARBOPLATIN",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "P02170101卡伯拉丁注射液Carboplatin-final-103-01-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021701&Seq=002&Type=9"
        },
        {
            "title": "020217010001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021701&Seq=001&Type=9"
        }
    ]
}